SCHEMBL462000

SCHEMBL462000

C=C(C#N)C(=O)OC(C)OCC

nearest known ligand 0.56

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
TSHR P16473 1/20 0.56
LMNA P02545 1/20 0.38
CYP2C9 P11712 1/20 0.31
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
MAPT P10636 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4888281 0.86 ALDH1A1 (0.49) ALDH1A1TSHR
SCHEMBL4889694 0.85 ALDH1A1 (0.49) ALDH1A1TSHR
SCHEMBL6466646 0.85 TSHR (0.49) ALDH1A1TSHRLMNA
SCHEMBL16872718 0.84 ALDH1A1 (0.46) ALDH1A1TSHR
SCHEMBL26099575 0.84 ALDH1A1 (0.46) ALDH1A1TSHR
SCHEMBL4891378 0.83 TSHR (0.46) ALDH1A1TSHRLMNA
SCHEMBL11802505 0.83 ALDH1A1 (0.44) ALDH1A1TSHR
SCHEMBL448845 0.81 TSHR (0.55) ALDH1A1TSHRMAPT
SCHEMBL4893053 0.81 ALDH1A1 (0.43) ALDH1A1TSHR
SCHEMBL9058082 0.81 ALDH1A1 (0.43) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260041183-A1 ADHESIVE FOR COSMETIC ARTICLE AND METHOD OF FORMING FULLER H B CO (US) 2026-02-12 US claimed
CN-116209729-B Thickener for cyanoacrylate-based adhesives 旭化成株式会社 2025-04-08 CN claimed
CN-117462729-A Polycyanoacrylic acid-cyanoacrylate embolism microsphere, preparation method and application thereof 北京康派特医疗器械有限公司 2024-01-30 CN claimed
US-20230364304-A1 METHODS OF FORMING BONE INTERFACE SCAFFOLDS Sparta Biopharma LLC (US) 2023-11-16 US claimed
US-11813375-B2 Therapeutic agent for solid cancer YANCHERS INC. (JP) 2023-11-14 US claimed
EP-3691860-B1 PHOTORESPONSIVE MATERIALS FOR VOLUMETRIC ADDITIVE MANUFACTURING ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) 2023-07-19 EP claimed
CN-115627124-A Low-whitening impact-resistant quick-drying adhesive composition and preparation method thereof 上海兰盛新材料科技有限公司 2023-01-20 CN claimed
CN-115362230-A Low odor cyanoacrylate compositions 汉高股份有限及两合公司 2022-11-18 CN claimed
CN-115054723-B Flexible adhesive 苏州美创医疗科技有限公司 2022-11-15 CN claimed
CN-115054723-A Flexible adhesive 苏州美创医疗科技有限公司 2022-09-16 CN claimed
WO-2002020069-A2 ANTIOXIDANT ENRICHED ADHESIVE COMPOSITIONS AND STORAGE CONTAINERS THEREFOR CLOSURE MEDICAL CORPORATION (US) 2002-03-14 WO claimed
EP-0824316-A4 COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH NIELSEN THOR B (US) 2001-01-17 EP claimed
EP-0965623-A1 Stabilized monomer adhesive compositions Closure Medical Corporation (US) 1999-12-22 EP claimed
US-5767152-A USING A CYANOCARBOXYLIC ACID S.N. BIOTECH, INC. 1998-06-16 US claimed
EP-0824316-A1 COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH Nielsen, Thor, B. (US) 1998-02-25 EP claimed
WO-1996034526-A1 COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH NIELSEN THOR B (US) 1996-11-07 WO claimed
US-5536799-A DIPENTAERYTHRITOL POLYACRYLATE TOAGOSEI CO., LTD. (JP) 1996-07-16 US claimed
US-5135784-A Wrapping web container and cutter for cutting wrapping web AYAKO OKUMURA (JP) 1992-08-04 US claimed
EP-0163757-A1 Adhesive composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-12-11 EP claimed
US-4496685-A COMPRISING ALPHA CYANOACRYLATE MONOMER AND A PHOSPHAZENE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-01-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260041183-A1 ADHESIVE FOR COSMETIC ARTICLE AND METHOD OF FORMING KRT18, CDH1, CFL1 ALDH1A1 556/4885TSHR 3226/4885LMNA 2974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.